Edit |   |
---|---|
Antigenic Specificity | CB2 (C-term), 329-356 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.08 mL, 0.4 mL |
Concentration | vial concentration: 0.5 |
Applications | ELISA (EIA), Immunohistochemistry (IHC), Flow Cytometry (FC/FACS), Western Blot (WB) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This CB2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 329-356 amino acids from the C-terminal region of human CB2. The cannabinoid delta-9-tetrahydrocannabinol is theprincipal psychoactive ingredient of marijuana. The proteinsencoded by this gene and the cannabinoid receptor 1 (brain) (CNR1)gene have the characteristics of a guanine nucleotide-bindingprotein (G-protein)-coupled receptor for cannabinoids. They inhibitadenylate cyclase activity in a dose-dependent, stereoselective,and pertussis toxin-sensitive manner. These proteins have beenfound to be involved in the cannabinoid-induced CNS effects(including alterations in mood and cognition) experienced by user |
Immunogen | n/a |
Other Names | [Cannabinoid receptor 2; CB-2; CB2; hCB2; CX5; CNR2; CB2A; CB2B] |
Gene, Accession # | [CNR2], Gene ID: 1269, NCBI: NP_001832.1, UniProt: P34972 |
Catalog # | MBS9203911 |
Price | $165, $370 |
Order / More Info | CB2 (C-term), 329-356 Antibody from MYBIOSOURCE INC. |
Product Specific References | Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Larrinaga, G., et al. Histol. Histopathol. 25(9):1133-1138(2010) Pinheiro, A.P., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (5), 1070-1080 (2010) : Taylor, A.H., et al. Histochem. Cell Biol. 133(5):557-565(2010) De Jesus, M.L., et al. Neurochem. Int. 56 (6-7), 829-833 (2010) : |